Skip to main content
Drug for ulcerative colitis in children gets orphan status
8/11/2017

Cobitolimod, Index Pharmaceuticals' drug candidate for ulcerative colitis, has gained an orphan drug designation from the FDA as a treatment of children. The Toll-like receptor 9 agonist is in midstage trials for adults.

Full Story: